Dermatitis
MONDO:0002406An inflammatory process affecting the skin. Signs include red rash, itching, and blister formation. Representative examples are contact dermatitis, atopic dermatitis, and seborrheic dermatitis.
Also known as: inflammation of skin, inflammation of the skin, inflammation of zone of skin, inflammatory skin disease, skin inflammation, zone of skin inflammation
1623 clinical trials for this condition and its sub-types, 65 tagged with Dermatitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Dermatitis
-
Atopic eczema 467 trials · 480 incl. sub-types
3 sub-types
- Allergic contact dermatitis 10 trials Sub-types →
- Allergic urticaria 3 trials · 5 incl. sub-types Sub-types →
- Allergic cutaneous vasculitis 1 trial
-
Psoriasis 379 trials
3 sub-types
- Pustular psoriasis 6 trials · 39 incl. sub-types Sub-types →
- Guttate psoriasis 2 trials
- Psoriasis 2 0 trials
-
Urticaria 28 trials · 164 incl. sub-types
14 sub-types
- Angioedema 19 trials · 66 incl. sub-types Sub-types →
- Idiopathic urticaria 0 trials · 66 incl. sub-types Sub-types →
- Chronic urticaria 12 trials · 20 incl. sub-types Sub-types →
- Physical urticaria 3 trials · 15 incl. sub-types Sub-types →
- Cold urticaria 10 trials
- Allergic urticaria 3 trials · 5 incl. sub-types Sub-types →
- Drug rash with eosinophilia and systemic symptoms 5 trials
- Cutaneous mastocytosis 1 trial Sub-types →
- Urticaria, aquagenic 1 trial
- Urticaria, familial localized heat 1 trial
- Melkersson-Rosenthal syndrome 0 trials
- Autoimmune urticaria 0 trials
- Papular urticaria 0 trials
- Pruritic urticarial papules and plaques of pregnancy 0 trials
-
Skin infection 12 trials · 152 incl. sub-types
14 sub-types
- Tinea infection 1 trial · 116 incl. sub-types Sub-types →
- Scabies 12 trials Sub-types →
- Demodex folliculitis 5 trials
- Impetigo 5 trials Sub-types →
- Infection by Trypanosoma gambiense 3 trials
- Erysipelas 1 trial
- Pthirus pubis infestation 0 trials
- Cercarial dermatitis 0 trials
- Cutaneous diphtheria 0 trials
- Furunculosis 0 trials
- Gonococcal keratitis 0 trials
- Herpes simplex dermatitis 0 trials
- Herpes zoster dermatitis 0 trials Sub-types →
- Sycosis barbae 0 trials
-
Vitiligo 100 trials
3 sub-types
- Generalized vitiligo 16 trials
- Alopecia universalis onychodystrophy vitiligo 0 trials
- Trichrome vitiligo 0 trials
-
Dermatomyositis 81 trials · 100 incl. sub-types
11 sub-types
- Juvenile dermatomyositis 41 trials
- Anti-MDA5 dermatomyositis 3 trials
- Clinically amyopathic dermatomyositis 1 trial · 2 incl. sub-types Sub-types →
- Adermatopathic dermatomyositis 0 trials
- Adult dermatomyositis 0 trials
- Anti-Mi2 dermatomyositis 0 trials
- Anti-NXP2 dermatomyositis 0 trials
- Anti-SAE dermatomyositis 0 trials
- Anti-TIF1 dermatomyositis 0 trials
- Classical dermatomyositis 0 trials
- Neonatal dermatomyositis 0 trials
-
Acne 91 trials
1 sub-type
- Adult acne 0 trials
-
Autoimmune bullous skin disease 7 trials · 55 incl. sub-types
11 sub-types
- Pemphigus 20 trials · 27 incl. sub-types Sub-types →
- Bullous pemphigoid 18 trials
- Mucous membrane pemphigoid 5 trials · 9 incl. sub-types Sub-types →
- Acquired epidermolysis bullosa 3 trials
- Dermatitis herpetiformis 1 trial Sub-types →
- Pemphigoid 1 trial
- IgA pemphigus 0 trials
- Anti-p200 pemphigoid 0 trials
- Linear IgA Dermatosis 0 trials
- Paraneoplastic pemphigus 0 trials
- Subcorneal pustular dermatosis 0 trials
-
Lichen planus 19 trials · 47 incl. sub-types
11 sub-types
- Lichen planus, oral 30 trials
- Lichen planus pigmentosus 2 trials
- Atrophic lichen planus 1 trial
- Hypertrophic lichen planus 1 trial
- Actinic lichen planus 0 trials
- Annular atrophic lichen planus 0 trials
- Annular lichen planus 0 trials
- Bullous lichen planus 0 trials
- Lichen planus pemphigoides 0 trials
- Lichen planus, familial 0 trials
- Linear lichen planus 0 trials
-
Radiodermatitis 37 trials · 42 incl. sub-types
1 sub-type
- Photosensitivity disease 4 trials · 5 incl. sub-types Sub-types →
-
Contact dermatitis 9 trials · 24 incl. sub-types
4 sub-types
- Allergic contact dermatitis 10 trials Sub-types →
- Irritant dermatitis 9 trials Sub-types →
- Contact dermatitis due to nickel 1 trial
- Occupational dermatitis 1 trial
-
Lichen sclerosus et atrophicus 10 trials · 20 incl. sub-types
1 sub-type
- Vulvar lichen sclerosus 15 trials
-
Seborrheic dermatitis 15 trials
1 sub-type
- Seborrheic infantile dermatitis 0 trials
-
Neurodermatitis 10 trials
-
Folliculitis 1 trial · 8 incl. sub-types
4 sub-types
- Demodex folliculitis 5 trials
- Acne keloid 1 trial
- Eosinophilic pustular folliculitis 1 trial Sub-types →
- Sycosis barbae 0 trials
-
Neurotic excoriation 5 trials
-
Cutaneous vasculitis 4 trials · 5 incl. sub-types
1 sub-type
- Allergic cutaneous vasculitis 1 trial
-
Acanthosis nigricans 4 trials
2 sub-types
-
Acneiform dermatitis 4 trials
-
Hydroa vacciniforme 2 trials
1 sub-type
- Hydroa vacciniforme, familial 0 trials
-
Acrodermatitis 0 trials · 2 incl. sub-types
1 sub-type
- Acrodermatitis chronica atrophicans 2 trials
-
Exfoliative dermatitis 1 trial
-
Granuloma annulare 1 trial
-
Lipodermatosclerosis 1 trial
-
Parapsoriasis 0 trials · 1 incl. sub-types
3 sub-types
- Pityriasis lichenoides 1 trial Sub-types →
- Large plaque parapsoriasis 0 trials
- Small plaque parapsoriasis 0 trials
-
Porphyria cutanea tarda 0 trials · 1 incl. sub-types
3 sub-types
- Familial porphyria cutanea tarda 1 trial
- Hepatoerythropoietic porphyria 0 trials
- Sporadic porphyria cutanea tarda 0 trials
-
Dermatosis papulosa nigra 0 trials
-
Food dermatitis 0 trials
-
Granulomatous dermatitis 0 trials
-
Intertrigo 0 trials
-
Pityriasis rosea 0 trials
-
Spongiotic dermatitis 0 trials
Most studied deeper sub-types
-
New pill could ease painful skin condition
Disease control OngoingThis phase 3 study tests an oral drug called remibrutinib in 565 people with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps. Participants receive one of two doses of remibrutinib or a placebo for 68 weeks. The main goal is to see …
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 23, 2026 00:00 UTC
-
New pill could ease painful skin condition
Disease control OngoingThis phase 3 trial tests an oral drug called remibrutinib in 588 people with moderate to severe hidradenitis suppurativa (HS), a chronic skin condition causing painful lumps. The study compares two doses of the drug against a placebo over 68 weeks. The main goal is to see if the …
Phase 3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can a new drug safely control eczema over the long haul?
Disease control By invitation onlyThis trial is investigating whether long-term use of an experimental drug called IMG-007 can safely control moderate-to-severe eczema (atopic dermatitis). The study enrolls people who have already completed a previous IMG-007 trial and will receive the drug as a shot under the sk…
Phase 2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
New antibody drug aims to calm painful skin condition
Disease control OngoingThis Phase 2 trial tests tibulizumab, a dual-action antibody, in 225 adults with hidradenitis suppurativa (HS), a chronic skin condition causing painful abscesses. Participants first receive either the drug or a placebo for 16 weeks, then everyone gets the drug for another 16 wee…
Phase 2 • Sponsor: Zura Bio Inc • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug shows promise for regrowing hair in severe alopecia
Disease control OngoingThis study tests a drug called bempikibart (ADX-914) in 75 adults with severe alopecia areata, a condition causing significant scalp hair loss. In the first part, some participants received the drug and some a placebo to see if it helps hair regrow. The second part gives the drug…
Phase 2 • Sponsor: Q32 Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Eczema drug trial could mean fewer shots for patients
Disease control OngoingThis study tests the drug lebrikizumab in 520 adults and teens (ages 12+) with moderate-to-severe eczema. Part 1 looks at how well the drug improves skin symptoms over 24 weeks. Part 2 compares a new dosing schedule (every 12 weeks) to the current one (every 4 weeks) to see if it…
Phase 3 • Sponsor: Almirall, S.A. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New eczema drug shows promise in Mid-Stage trial
Disease control OngoingThis study tests whether ATI-045 can safely reduce eczema symptoms like redness, itching, and skin patches in people with moderate-to-severe disease. About 110 adults who haven't had success with topical treatments will receive either the drug or a placebo. The main goal is to se…
Phase 2 • Sponsor: Aclaris Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could an existing eczema drug help a rare skin condition?
Disease control OngoingThis Phase 2 trial tests dupilumab (Dupixent), an injectable drug already approved for atopic dermatitis, in 70 adults with nummular eczema, a chronic, itchy skin condition. Participants receive either dupilumab or a placebo for several weeks. The study measures changes in eczema…
Phase 2 • Sponsor: Technical University of Munich • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Baby eczema cream may stop food allergies before they start
Prevention OngoingThis study tests whether using a special skin barrier cream (Epiceram) twice a day, along with a steroid cream at the first sign of eczema, can prevent food allergies in babies who develop eczema by 12 weeks old. The goal is to see if this proactive skin care reduces the number o…
Phase 2 • Sponsor: Kari Nadeau, MD, PhD • Aim: Prevention
Last updated Jun 27, 2026 09:08 UTC
-
Could a cheap gout pill soothe radiation burns?
Symptom relief OngoingThis early-stage study tests whether a low dose of colchicine, a medicine usually used for gout, can safely reduce skin redness and pain caused by radiation therapy in people with head and neck cancer. About 30 participants take one pill daily during their radiation treatment. Th…
Phase 1 • Sponsor: Rutgers, The State University of New Jersey • Aim: Symptom relief
Last updated Jun 27, 2026 12:35 UTC
-
Light therapy eases mouth sores and skin burns in 33,000 cancer patients
Symptom relief OngoingThis real-world study follows 33,000 cancer patients in France using the CareMin650™ device, which shines light on mouth sores and skin burns caused by chemotherapy or radiation. The goal is to see if this light therapy reduces the severity of these painful side effects. Research…
Sponsor: Centre Hospitalier de Valenciennes • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Scientists probe immune secrets of four skin diseases
Knowledge-focused By invitation onlyThis study aims to understand inflammation in four chronic skin conditions: vitiligo, psoriasis, eczema (atopic dermatitis), and alopecia areata. Researchers will collect blood and small skin samples from 450 adults to analyze immune cells called T-cells. The goal is to describe …
Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Scientists use suction blisters to peek inside skin inflammation
Knowledge-focused OngoingThis study aims to understand how inflammation works in the skin and how certain anti-inflammatory drugs (biologics) affect it. Researchers will create small suction blisters on the skin of healthy volunteers and people with skin conditions, then analyze the fluid and cells. The …
Phase 2/3 • Sponsor: Wei-Che Ko • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC